Literature DB >> 25101371

[Not Available].

Tobias Welte.   

Abstract

Year:  2014        PMID： 25101371      PMCID： PMC7079926          DOI： 10.1007/s00063-014-0390-z

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  18 in total

Review 1.  Relative biological effectiveness of proton beams in clinical therapy.

Authors:  L E Gerweck; S V Kozin
Journal:  Radiother Oncol       Date:  1999-02       Impact factor: 6.280

2.  Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols.

Authors:  Masashi Mizumoto; Toshiyuki Okumura; Takayuki Hashimoto; Kuniaki Fukuda; Yoshiko Oshiro; Nobuyoshi Fukumitsu; Masato Abei; Atsushi Kawaguchi; Yasutaka Hayashi; Ayako Ookawa; Haruko Hashii; Ayae Kanemoto; Takashi Moritake; Eriko Tohno; Koji Tsuboi; Takeji Sakae; Hideyuki Sakurai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

3.  Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.

Authors:  Shannon E Fogh; David W Andrews; Jon Glass; Walter Curran; Charles Glass; Colin Champ; James J Evans; Terry Hyslop; Edward Pequignot; Beverly Downes; Eileen Comber; Mitchell Maltenfort; Adam P Dicker; Maria Werner-Wasik
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

4.  Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.

Authors:  G Minniti; V Armosini; M Salvati; G Lanzetta; P Caporello; M Mei; M F Osti; R Enrici Maurizi
Journal:  J Neurooncol       Date:  2010-11-05       Impact factor: 4.130

5.  Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.

Authors:  Richard Holy; Marc Piroth; Michael Pinkawa; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-03-21       Impact factor: 3.621

6.  Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

Authors:  Stephanie E Combs; Christoph Thilmann; Lutz Edler; Jürgen Debus; Daniela Schulz-Ertner
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

7.  Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer.

Authors:  Masashi Mizumoto; Shinji Sugahara; Hidetsugu Nakayama; Haruko Hashii; Akira Nakahara; Hideo Terashima; Toshiyuki Okumura; Koji Tsuboi; Koichi Tokuuye; Hideyuki Sakurai
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

8.  Relative biological effectiveness (RBE) values for proton beam therapy.

Authors:  Harald Paganetti; Andrzej Niemierko; Marek Ancukiewicz; Leo E Gerweck; Michael Goitein; Jay S Loeffler; Herman D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

9.  Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.

Authors:  Masashi Mizumoto; Koji Tsuboi; Hiroshi Igaki; Tetsuya Yamamoto; Shingo Takano; Yoshiko Oshiro; Yasutaka Hayashi; Haruko Hashii; Ayae Kanemoto; Hidetsugu Nakayama; Shinji Sugahara; Hideyuki Sakurai; Akira Matsumura; Koichi Tokuuye
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-19       Impact factor: 7.038

10.  Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

Authors:  Emmanouil Fokas; Ulrich Wacker; Markus W Gross; Martin Henzel; Elitsa Encheva; Rita Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.